Branded Medicines and Pipeline Successes Drive Teva Pharmaceutical Industries' (TEVA) Margin Expansion
TCW Funds, an investment management firm, published its second-quarter 2026 investor letter for the “TCW Relative Value Mid Cap Fund”. The letter can be downloaded here.








